Status
N/A
closed
Share
Funding data (30 December 2021)
Raised
EUR
698,962.00
Min. Goal
EUR
1,050,000.00
Details
Country
Afghanistan
Type
EquityEquity
End date
30 December 2021
(1235 days)
Description
“Aranda Pharma’s ADA-308 aims to be the first non-steroidal anti-androgen for topical treatment of acne.”